| ALZINOVA AB |
| Schweden |
| Gesundheit |
| SE0007413455 / A2N87T |
| 78D (Frankfurt) |
| FRA:78D, ETR:78D, 78D:GR |
| - |
| https://www.alzinova.com/ |
|
Alzinova AB is a Swedish biotechnology company focused on the development and innovation of therapeutics for the treatment of Alzheimer's disease. The company centers its research on proprietary technology aimed at targeting and neutralizing toxic am..
>Volltext.. |
| 8.55 Mio. EUR |
| 8.59 Mio. EUR |
| 0.01 Mio. EUR |
| - |
| -2.46 Mio. EUR |
| -0.03 EUR |
| 0.07 Mio. EUR |
| 0.03 Mio. EUR |
| -1.22 Mio. EUR |
| 0.02 |
| 249.68% |
| -35.42% |
| - |
| - |
| - |
| - |
| ALZINOVA |
| 04.04.26 |
|